Compugen Ltd (CGEN) awards COO Pierre Ferre 70,000 stock options
Rhea-AI Filing Summary
Compugen Ltd granted Chief Operating Officer Pierre Ferre 70,000 share options over ordinary shares at an exercise price of $4.00 per share, expiring on July 29, 2036. The option vests 25% on September 30, 2027, with the remainder vesting in 12 equal quarterly installments, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ferre Pierre
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (right to buy) F1 | 70,000 | $0.00 | $0.00 |
Holdings After Transaction:
Share Option (right to buy) — 70,000 shares (Direct)
Footnotes (1)
- F1. This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Options granted: 70,000 share options
Exercise price: $4.0000 per share
Expiration date: 2036-07-29
+2 more
5 metrics
Options granted
70,000 share options
Grant to Chief Operating Officer Pierre Ferre on 2026-07-29
Exercise price
$4.0000 per share
Exercise price of the granted share options
Expiration date
2036-07-29
Expiration of Ferre’s share option award
Initial vesting
25% on September 30, 2027
Portion of the options vesting on the first vesting date
Remaining vesting installments
12 equal quarterly installments
Balance of the options vests quarterly after initial vesting, subject to continued service
Key Terms
Share Option (right to buy), exercise price, vests, quarterly installments
4 terms
exercise price financial
"Options carry an exercise price of $4.0000 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests financial
"This option vests 25% on September 30, 2027"
quarterly installments financial
"The remainder vests in 12 equal quarterly installments thereafter"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock option grant did COMPUGEN (CGEN) report for Pierre Ferre?
Compugen granted Chief Operating Officer Pierre Ferre 70,000 share options over ordinary shares at an exercise price of $4.00 per share. The options were awarded on July 29, 2026 and represent a new equity-based compensation grant.
What is the exercise price of Pierre Ferre’s new COMPUGEN (CGEN) options?
The granted share options carry an exercise price of $4.00 per share. This means Ferre may purchase up to 70,000 ordinary shares at $4.00 each once the options have vested and before they expire on July 29, 2036.
When do Pierre Ferre’s COMPUGEN (CGEN) options start vesting?
The option grant begins vesting on September 30, 2027, when 25% of the award vests. The remaining options then vest in 12 equal quarterly installments, so the position builds gradually over several years, assuming his continued service with Compugen.
How long will Pierre Ferre’s COMPUGEN (CGEN) stock options remain exercisable?
The share options granted to Pierre Ferre expire on July 29, 2036. He may exercise vested portions any time after they vest and before this expiration date, subject to the company’s equity plan terms and applicable securities-law and trading restrictions.
What conditions apply to the vesting of COMPUGEN (CGEN) options granted to Pierre Ferre?
Vesting of the award is subject to Pierre Ferre’s continued service with Compugen. Twenty-five percent vests on September 30, 2027, and the remaining 75% vests in 12 equal quarterly installments thereafter, so leaving the company early could limit the vested portion.